IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q4 2017 Holdings

Filed 2018-02-14 | 6 holdings | $169.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$77.5K$95,045,00045.9%
Vivus IncNOTE 4.500% 5/0928551AB6$38.8K$60,000,00022.9%
PTC Therapeutics IncNOTE 3.000% 8/169366JAB7$36.7K$45,567,00021.7%
Sucampo Pharmaceuticals IncNOTE 3.250%12/1864909AA4$14.7K$12,000,0008.7%
Apollo Endosurgery Inc(HQ8F)COM03767D108$1.4K252,0790.8%